Balyasny Asset Management’s Arcutis Biotherapeutics ARQT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-427,433
| Closed | -$6.69M | – | 1984 |
|
|
2025
Q1 | $6.69M | Buy |
427,433
+324,292
| +314% | +$5.07M | 0.01% | 778 |
|
|
2024
Q4 | $1.44M | Buy |
+103,141
| New | +$1.44M | ﹤0.01% | 1176 |
|
|
2024
Q3 | – | Sell |
-437,362
| Closed | -$4.07M | – | 1941 |
|
|
2024
Q2 | $4.07M | Sell |
437,362
-343,418
| -44% | -$3.19M | 0.01% | 876 |
|
|
2024
Q1 | $7.74M | Buy |
+780,780
| New | +$7.74M | 0.01% | 760 |
|
|
2023
Q4 | – | Sell |
-38,069
| Closed | -$202K | – | 1903 |
|
|
2023
Q3 | $202K | Buy |
+38,069
| New | +$202K | ﹤0.01% | 1553 |
|
|
2023
Q2 | – | Sell |
-44,288
| Closed | -$487K | – | 1845 |
|
|
2023
Q1 | $487K | Buy |
+44,288
| New | +$487K | ﹤0.01% | 1543 |
|